Canada · Federal contract register · Contract
Pharmaceutical and other medicinal products — Canada · Federal contract register · Contract: $10.7M contract value ($10,692,002); No competition how it was bought (Advance Contract Award Notice: one supplier named in advance); 2025 contract date (21 March 2025).
Assay record ASY-CA-075BI8I0PC · Cite as: Assay Systems, “Pharmaceutical and other medicinal products · National Defence · Emergent Biosolutions Canada Inc.”, https://assay-systems.com/register/ca/contract/c-2025-2026-q1-04661/
| Department | National Defence |
|---|---|
| Supplier | Emergent Biosolutions Canada Inc. |
| Contract date | 21 March 2025 |
| Period | 15 July 2022 – 31 March 2032 |
| Value | $10,692,002 |
| Original value | $0 |
| Amendments | $3,781,604 |
| Procedure | Non-competitive (Advance Contract Award Notice: one supplier named in advance) |
| Bids received | not stated |
| Economic object code | 1132 |
The department awarded it without a competition. Emergent Biosolutions Canada Inc. took $10,692,002 with no other bid on the table.
Proactive disclosure of contracts over $10,000, Government of Canada, open.canada.ca, under the Open Government Licence – Canada. Where a contract was amended, the page carries the last report filed for it.
Contains information licensed under the Open Government Licence – Canada.Source: Government of Canada proactive disclosure of contracts.